Division of Genetic Medicine and Clinical Pharmacology Archive — Page 8 of 11
-
April 11, 2022
Peptides promote AFib arrhythmia
Peptide oligomers have detrimental metabolic effects and cause pro-arrhythmic electrophysiological changes in heart atria, suggesting they may contribute to atrial fibrillation. -
March 17, 2022
U.S. precision medicine research program releases genomic data
The All of Us Research Program released an initial large batch of genomic data on its cloud-based research platform, the Researcher Workbench, including whole genome sequences of 98,600 research participants and genotype data from 165,200 participants. -
February 24, 2022
VUMC researchers find clue to drug-induced arrhythmias
Vanderbilt University Medical Center researchers have made a fundamental discovery about how the heart compensates for genetic variations that otherwise could trigger abnormal and potentially fatal heart rhythms. -
February 23, 2022
VUMC designated a Tourette syndrome center of excellence
The Vanderbilt Center for Tourette Syndrome and Other Tic Disorders has been designated a Tourette Association of America (TAA) Center of Excellence. -
December 2, 2021
Gene discoveries give new hope to people who stutter
New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter. -
December 2, 2021
Study links depression scores, white blood cell count
-
November 30, 2021
Study examines genetic risk for suicide attempt
New research from Vanderbilt identifies the first replicated genomic region contributing to risk of suicide attempt and confirms that genetic risk for the trait is not driven solely by risk for psychiatric disorders.